Bendamustine Hydrochloride
Product Images NDC 68001-571

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bendamustine Hydrochloride (NDC 68001-571). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg Carton (Bendamustine 100mg Carton)

100mg Carton (Bendamustine 100mg Carton)
This is a product label for a drug called Bendamustine Hydrochloride for injection. It comes in a single-dose vial of 100mg/vial and is for intravenous infusion only. The drug needs to be reconstituted and diluted using sterile water for injection. The recommended dosage is not provided. The drug contains Mannitol and is considered a cytotoxic agent that requires caution during preparation and handling. Rx only. Manufactured by Intas Pharmaceuticals Limited, Ahmedabad, India, for BluePoint Laboratories. The NDC (National Drug Code) for the drug is 68001-572-41. The label provides instructions for storage and handling, including storing the drug between 2.8°C to 35°C, protecting it from light, and discarding unused portions. The label also warns users to use gloves and water glasses during handling and prepare the drug immediately after the reconstitution. Detailed instructions are provided in the insert.*
FDA Label Image

100mg Vial (Bendamustine 100mg Label)

100mg Vial (Bendamustine 100mg Label)
This is a medication containing Bendamustine Hydrochloride and Mannitol, used for intravenous infusion only. It comes in a powder form which must be reconstituted with sterile water and then mixed with Sodium Chloride injection or Dextiose Sodium Chloride injection. Dosage guidance can be found in the insert. It is manufactured by Intas Pharmaceuticals Limited and should be stored in the original package at or below 25°C(77°F), protected from light. Unused portion needs to be discarded. Lot and EXP can be found on the packaging.*
FDA Label Image

25mg Carton (Bendamustine 25mg Carton)

25mg Carton (Bendamustine 25mg Carton)
This appears to be a medical description of a medication called "Bendamustine Hydrochloride for Injection". The text provides information about the concentration, dosage, and instructions for use. It also includes warnings and precautions related to proper handling and disposal of the medication.*
FDA Label Image

25ml Vial Label (Bendamustine 25mg Label)

25ml Vial Label (Bendamustine 25mg Label)
This is a medication that contains 25 mg of Bendamustine Hydrochloride, USP and 42.5 mg of Mannitol, USP for intravenous infusion only. The medication must be reconstituted immediately with 5 mL of sterile water for injection, USP to a concentration of 5 mg/mL. The recommended dosage must be consulted before use. It is available in a 25 mg/vial and must be stored up to 25°C (77°F), protected from light, and away from moisture. The manufacturing company is Intas Pharmaceuticals Limited located in Ahmedabad, India. The label contains a barcode for batch coding and data matrix. *
FDA Label Image

Figure 1. Progression-free Survival (Bendamustine Fig 1)

FDA Label Image

Structural Formula (Bendamustine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.